Renee D. Gala

2016

In 2016, Renee D. Gala earned a total compensation of $2.2M as SVP and Chief Financial Officer, Treasurer at Theravance Biopharma, a 25% decrease compared to previous year.

Compensation breakdown

Bonus$75,167
Non-Equity Incentive Plan$171,810
Salary$429,525
Stock Awards$1,526,400
Other$5,000
Total$2,207,902

Gala received $1.5M in stock awards, accounting for 69% of the total pay in 2016.

Gala also received $75.2K in bonus, $171.8K in non-equity incentive plan, $429.5K in salary and $5K in other compensation.

Rankings

In 2016, Renee D. Gala's compensation ranked 4,440th out of 14,075 executives tracked by ExecPay. In other words, Gala earned more than 68.5% of executives.

ClassificationRankingPercentile
All
4,440
out of 14,075
69th
Division
Manufacturing
1,560
out of 5,486
72nd
Major group
Chemicals And Allied Products
471
out of 1,900
75th
Industry group
Drugs
343
out of 1,543
78th
Industry
Pharmaceutical Preparations
268
out of 1,173
77th
Source: SEC filing on March 21, 2018.

Gala's colleagues

We found three more compensation records of executives who worked with Renee D. Gala at Theravance Biopharma in 2016.

2016

Rick Winningham

Theravance Biopharma

Chief Executive Officer

2016

Bradford Shafer

Theravance Biopharma

General Counsel

2016

Frank Pasqualone

Theravance Biopharma

Senior Vice President and Global Head, Acute Care Business

News

You may also like